195 related articles for article (PubMed ID: 24089532)
1. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.
Mavrommatis E; Arslan AD; Sassano A; Hua Y; Kroczynska B; Platanias LC
J Biol Chem; 2013 Nov; 288(46):33006-15. PubMed ID: 24089532
[TBL] [Abstract][Full Text] [Related]
2. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.
Katsoulidis E; Mavrommatis E; Woodard J; Shields MA; Sassano A; Carayol N; Sawicki KT; Munshi HG; Platanias LC
J Biol Chem; 2010 Dec; 285(51):40333-41. PubMed ID: 20956525
[TBL] [Abstract][Full Text] [Related]
3. Human Schlafen 5 (SLFN5) Is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells.
Sassano A; Mavrommatis E; Arslan AD; Kroczynska B; Beauchamp EM; Khuon S; Chew TL; Green KJ; Munshi HG; Verma AK; Platanias LC
Mol Cell Biol; 2015 Aug; 35(15):2684-98. PubMed ID: 26012550
[TBL] [Abstract][Full Text] [Related]
4. Loss of Schlafen3 influences the expression levels of Schlafen family members in ileum, thymus, and spleen tissue.
Vomhof-DeKrey EE; Umthun J; Basson MD
PeerJ; 2020; 8():e8461. PubMed ID: 32025381
[TBL] [Abstract][Full Text] [Related]
5. Vil-Cre specific Slfn3KO mice exhibit sex-specific differences in lung, stomach, cecum, kidney, and proximal colon differentiation markers and Slfn family members expression levels.
Vomhof-DeKrey EE; Rajpathy OK; Preszler E; Basson MD
Biochem Biophys Rep; 2023 Dec; 36():101552. PubMed ID: 38076659
[TBL] [Abstract][Full Text] [Related]
6. Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responses.
Katsoulidis E; Carayol N; Woodard J; Konieczna I; Majchrzak-Kita B; Jordan A; Sassano A; Eklund EA; Fish EN; Platanias LC
J Biol Chem; 2009 Sep; 284(37):25051-64. PubMed ID: 19592487
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis.
van Zuylen WJ; Garceau V; Idris A; Schroder K; Irvine KM; Lattin JE; Ovchinnikov DA; Perkins AC; Cook AD; Hamilton JA; Hertzog PJ; Stacey KJ; Kellie S; Hume DA; Sweet MJ
PLoS One; 2011 Jan; 6(1):e15723. PubMed ID: 21249125
[TBL] [Abstract][Full Text] [Related]
8. The Schlafen family: complex roles in different cell types and virus replication.
Liu F; Zhou P; Wang Q; Zhang M; Li D
Cell Biol Int; 2018 Jan; 42(1):2-8. PubMed ID: 28460425
[TBL] [Abstract][Full Text] [Related]
9. Vil-Cre specific Schlafen 3 knockout mice exhibit sex-specific differences in intestinal differentiation markers and Schlafen family members expression levels.
Vomhof-DeKrey EE; Stover AD; Labuhn M; Osman MR; Basson MD
PLoS One; 2021; 16(10):e0259195. PubMed ID: 34710177
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells.
Puck A; Aigner R; Modak M; Cejka P; Blaas D; Stöckl J
Results Immunol; 2015; 5():23-32. PubMed ID: 26623250
[TBL] [Abstract][Full Text] [Related]
11. Effect of Schlafen 2 on natural killer and T cell development from common T/natural killer progenitors.
Ahmadi S; Veinotte LL
Pak J Biol Sci; 2011 Nov; 14(22):1002-10. PubMed ID: 22514877
[TBL] [Abstract][Full Text] [Related]
12. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
Front Immunol; 2022; 13():922138. PubMed ID: 36090985
[TBL] [Abstract][Full Text] [Related]
13. The schlafen family of proteins and their regulation by interferons.
Mavrommatis E; Fish EN; Platanias LC
J Interferon Cytokine Res; 2013 Apr; 33(4):206-10. PubMed ID: 23570387
[TBL] [Abstract][Full Text] [Related]
14. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
15. Elevated S100A6 (Calcyclin) enhances tumorigenesis and suppresses CXCL14-induced apoptosis in clear cell renal cell carcinoma.
Lyu XJ; Li HZ; Ma X; Li XT; Gao Y; Ni D; Shen DL; Gu LY; Wang BJ; Zhang Y; Zhang X
Oncotarget; 2015 Mar; 6(9):6656-69. PubMed ID: 25760073
[TBL] [Abstract][Full Text] [Related]
16. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
17. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
18. Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB Pathway.
Fischietti M; Arslan AD; Sassano A; Saleiro D; Majchrzak-Kita B; Ebine K; Munshi HG; Fish EN; Platanias LC
Mol Cell Biol; 2018 Aug; 38(16):. PubMed ID: 29866656
[TBL] [Abstract][Full Text] [Related]
19. Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
Arslan AD; Sassano A; Saleiro D; Lisowski P; Kosciuczuk EM; Fischietti M; Eckerdt F; Fish EN; Platanias LC
Oncogene; 2017 Oct; 36(43):6006-6019. PubMed ID: 28671669
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation.
Shao J; Shi T; Yu H; Ding Y; Li L; Wang X; Wang X
EMBO J; 2021 Oct; 40(20):e107480. PubMed ID: 34269483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
